Who has invested in BioIntelliSense?

No investors are named on the public record for BioIntelliSense yet.

BioIntelliSense Funding: $70M Raised, Series B (2021)

BioIntelliSense funding overview

BioIntelliSense has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for BioIntelliSense runs through 2021; nothing later has been disclosed.

BioIntelliSense at a glance

Total raised: $70M
Latest round: Series B
Latest round date: August 2021

Frequently asked about BioIntelliSense funding

How much has BioIntelliSense raised?: BioIntelliSense has raised $70M in total disclosed funding across the rounds on record.
Who has invested in BioIntelliSense?: No investors are named on the public record for BioIntelliSense yet.
What was the latest BioIntelliSense funding round?: The most recent disclosed round is a Series B, announced in August 2021.
Where is BioIntelliSense based?: No headquarters location is disclosed for BioIntelliSense.
When did BioIntelliSense last raise?: The last disclosed BioIntelliSense round closed in August 2021 at Series B.

BioIntelliSense totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

BioIntelliSense Funding: $70M Raised, Series B (2021)

BioIntelliSense funding overview

BioIntelliSense at a glance

Frequently asked about BioIntelliSense funding

Companies related to BioIntelliSense (30)

Browse related funding lists (3)